REFERENCES
- Weinstein IM. Idiopathic myelofibrosis: historical review, diagnosis and management. Blood Rev 1991;5:98–104.
- Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255–1265.
- Abe Y, Ohshima K, Shiratsuchi M, Honda K, Nishimura J, Nawata H, Muta K. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta. Eur J Haematol 2001;66:210–212.
- Uehara E, Tasaka T, Matsuhashi Y, Fujita M, Tamura T, Shimoura Y, Mano S, Kuwajima M, Nagai M. Peripheral T-cell lymphoma presenting with rapidly progressing myelofi-brosis. Leuk Lymphoma 2003;44:361–363.
- Rao SA, Gottesman Sr, Nguyen MC, Braverman AS. T cell lymphoma associated with myelofibrosis. Leuk Lymph 2003;44:715–718.
- Takai K, Sanada M. Peripheral T-cell lymphoma initially presenting as secondary myelofibrosis. Rinsho Ketsueki 1989;30:2199-2204 [in Japanese].
- Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L, Tilly H, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998;92:76–82.
- Kimura A, Katoh 0, Hyodo H, Kuramoto A. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br J Haematol 1989;72:486–491.
- Martyre MC. TGF-beta and megakaryocytes in the pathogen-esis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma 1995;20:39–44.
- Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350 — 1358.